Synthesis – Actuarial Consulting

Interesting Findings from our World Tour

Article 12 of 12

This series set to explore how different countries organize, finance, and deliver health care, and what can be learned from their differences.

This ‘final article’ provides a synthesis of what recurred across countries regardless of financing model, what turned out to be more nuanced than it first appeared, and where a few instincts about “what works” may not be supported through a critical review.

It also sets up the next phase of this project – articles dedicated to specific threads that weave through nearly all healthcare systems, not just these ten.

The Five-Domain Reckoning

Access to Care

Access splits along two separate axes, and countries in this series rarely succeed or fail on both at once.

The first axis is access into the system — whether the financing structure gets someone in the door at all. This is largely a coverage/insurance question: is care available regardless of ability to pay, and how comprehensive is the statutory basket once someone is covered.

The second axis is access within the system — whether, once covered, a person can actually reach a provider. This runs through physician supply (primary care vs. specialist distribution), geographic distribution (urban vs. rural, or even within-urban gaps), and the pathway design that gets a patient from first contact to the right level of care.

Most countries in this series succeed on one axis and fail on the other:

Canada succeeds on the first axis — universal Medicare covers everyone — and fails on the second: primary care attachment is declining and specialist wait times are chronic.

Sweden and the UK are similar cases: universal coverage, but their own capacity-driven wait-time problems on the provider side.

France has universal statutory coverage but a documented provider-access problem in its “medical deserts” — geographic maldistribution leaving both rural and some urban areas physician-short.

Germany and Japan succeed on both axes — universal coverage paired with high physician density and direct specialist access, so the absence of formal gatekeeping doesn’t become a bottleneck.

The United States is the outlier that fails on both simultaneously. Coverage gaps limit who can afford to seek care in the first place. And on the provider side, it isn’t just a distribution problem: the US has 2.6 physicians per 1,000 population, below the OECD average and well behind peers like the UK (3.2) or Austria (5.5), and that gap has been widening — physician growth per capita rose about 14% since 2000 in the US versus roughly 34% in comparably wealthy countries. On top of that undersupply, only about 12% of US physicians are generalists, so the doctors that do exist skew toward specialty care rather than primary care. Financing-axis failure and provider-axis failure compounding each other is what makes the US case distinct from Canada’s or France’s — not a single access problem, but two stacked on top of each other.

The finding worth carrying forward: “access” as a single domain score obscures more than it reveals. A country can look mediocre on the domain overall while actually having solved half the problem completely — and the fix required is entirely different depending on which axis is broken.

Care Process

Coordination doesn’t require one specific mechanism — three different routes show up across these ten systems, and the countries missing all of them struggle in similar ways regardless of financing model.

Formal gatekeeping is one route, not the only one. The Netherlands, UK, and Australia all tie strong care process performance to GP-led coordination. Germany is the clean counter-case: it names “limited formal care coordination and lack of gatekeeping” as a direct challenge, alongside high utilization with variable appropriateness. France sits in between — attending-GP designation is voluntary but financially steered (bypassing it cuts reimbursement from 70% to 30%), which has pushed group-practice participation from 54% to 69% of GPs since 2010, while still leaving a meaningful share of care solo and uncoordinated.

Structured chronic-disease programs are the more universal lever. Where a formal gatekeeper isn’t present, the coordination function gets built elsewhere: Germany’s disease management programs, France’s CPTS networks, Sweden’s multidisciplinary primary care teams, Singapore’s Healthier SG. Every one is a genuine strength and, in the same breath, incomplete — Germany’s DMPs are voluntary, France’s CPTS adoption “varies,” and over a third of Singaporeans still haven’t enrolled in Healthier SG. The lesson isn’t that one design wins — it’s that coordination has to be built deliberately somewhere, and even the best-built versions still have an adoption gap, not a design gap.

Mental health is the domain’s most consistent specific failure. Not just in outcomes — inside Care Process itself, as a stated challenge, in six of the ten articles: the Netherlands, UK, Canada, Japan, Sweden, and Singapore all name it directly, despite having little else in common structurally.

The United States shows why care process and access have to be scored separately. It is highly ranked on Care Process driven by strong preventive care and patient safety performance. But that strength is conditional: it reflects how well the system treats people who are already inside it and does nothing for the uninsured or underinsured who never reach the exam room where a mammogram or a safety protocol would apply. Excellent care process and the worst access record in the series can coexist in the same country, because they’re measuring two different things.

The takeaway: care process tells you how well a system treats the people already inside it, not who gets in. A country can excel here while failing on Access entirely — and mental health is the one place almost every country still falls short even for people already inside the system.

Administrative Efficiency

The number of payers turns out not to be the deciding factor — what matters is whether the system standardizes around them.

Multi-payer plus standardization can still be efficient. The Netherlands, Germany, and Japan all run multi-insurer systems and land in the “relatively efficient to moderately efficient” range because standardized benefits, central risk adjustment, or a nationally uniform fee schedule absorb the pricing chaos multiple payers would otherwise create. Japan states this most directly: its uniform fee schedule “eliminates much of the complexity that characterizes multi-payer systems elsewhere,” despite more than 3,000 separate insurers.

Single-payer doesn’t necessarily eliminate administrative cost — it relocates it. Canada, the UK, and Sweden all minimize patient-facing paperwork through tax-funded, single-payer financing. But the cost shows up elsewhere: Canada’s providers face complex fee schedules and duplicated records across 13 disconnected systems; Sweden’s burden is governance coordination across 21 autonomous regions and 290 municipalities rather than billing at all. “Single-payer” describes who collects the money, not whether the system is administratively simple end to end.

The United States is the outlier by a wide margin, and the mechanism is the absence of standardization, not the number of payers itself. It ranks ninth of ten nations on administrative efficiency, ahead of only Switzerland, with total administrative spending estimated at 15–30% of health expenditure — a burden no other country in the series comes close to. Hospitals report administrative costs exceeding 40% of total expenses, and physicians average 39 prior-authorization requests a week. The difference from Germany or Japan isn’t that the U.S. has more payers — it’s that nothing standardizes what any of them pay or how they bill, so every payer-provider relationship gets negotiated and adjudicated separately.

The takeaway: “how many payers” is the wrong question. “Is the system standardized around them” is the one that actually predicts administrative efficiency.

Equity

Universal coverage doesn’t eliminate equity gaps — it relocates them from “does this population have coverage” to something more specific, and what that something is varies more than the other domains suggest.

Most equity gaps in this series are bounded to an identifiable population, not diffuse. Canada and Australia both name Indigenous health disparities as their most acute unresolved equity failure — Canada’s life expectancy gap runs as high as 11 years for Inuit communities. Singapore’s is its nonresident population, roughly 30.7% of the total, excluded from subsidies by policy design. Japan’s is geographic — prefectures like Akita and Okinawa lag urban centers, with no Indigenous-population parallel. In each case, the gap has a name and a boundary, which makes it a defined policy target even when it’s politically hard to close.

Even the strongest-equity systems have a residual gap. Sweden pairs universal coverage with high-cost protection and still reports a north–south regional divide and language barriers for immigrant women in maternity care — plus a genuine paradox: its lowest income quintile carries higher lifetime health costs than its highest, despite lower life expectancy, reflecting heavier chronic disease burden without correspondingly better outcomes. Germany’s dual SHI/private-insurance structure means the privately insured, disproportionately healthier and wealthier, get faster access to some services inside an otherwise near-universal system.

Narrow benefit baskets translate directly into income-based inequity. Canada’s exclusion of drugs, dental, and most mental health care from Medicare means lower-income adults report more cost-related barriers and longer waits than the coverage numbers alone would suggest. France shows the same pattern inside a broader basket: unmet need runs 5.9% in the lowest income quintile versus 1.4% in the highest, and COVID-era mortality increases were more than five times higher among people born in sub-Saharan Africa than people born in France — with a professional interpreter available in only 36% of encounters where one was needed.

The United States is the one country in the series whose equity gap isn’t bounded to a single population. Life expectancy varies by more than 11 years by race, and by state of residence almost as sharply. The U.S. profile itself draws the contrast: unlike Singapore’s nonresident exclusion — “a bounded, identifiable population outside the system by policy design” — U.S. inequity is “diffuse, correlated with race, income, geography, and state of residence simultaneously,” which makes it both larger in aggregate and harder to address with any single policy lever.

The takeaway: nearly every system in this series has an equity failure somewhere. What separates them is whether that failure is bounded enough to target directly, or diffuse enough that no single reform reaches it.

Health Outcomes

Outcomes are the domain most likely to mislead if read as a direct verdict on system design, because spending and results consistently point in different directions.

Outcomes decouple from spending, in both directions. Singapore matches or beats France’s life expectancy at 4.9% of GDP versus France’s 11.5% — less than half the spend for the same result. Germany’s own outcomes fall short of what its spending would predict: preventable mortality from tobacco, alcohol, and chronic disease runs higher than several lower-spending Western European peers. The United States is the same pattern taken to its extreme — the highest health spending in the world, at 18% of GDP, and the worst outcomes of the ten: life expectancy of 78.5 years against a high-income average of 81.1, and avoidable mortality of 312 per 100,000, well above every other country in the series.

Even the strongest performers carry a specific, identifiable weak spot. Japan posts the best objective outcomes in the series — life expectancy of 84.1 years, low costs, preventable mortality among the world’s lowest — while also reporting a suicide rate above the OECD average and unusually high self-rated poor health, a combination its own profile treats as a genuine paradox rather than a footnote. Sweden shows nearly the same split: life expectancy more than three years above the high-income average, alongside suicide mortality above that same average and rising anxiety. France’s preventive screening lags its otherwise strong outcomes — only 47% of eligible women receive breast cancer screening, against an OECD average of 55%. No country in this series is uniformly strong across every outcome measure.

Mental health and suicide are the specific outcome where high performers keep falling short. Japan, Sweden, France, and Singapore all report suicide rates or self-reported mental health burden above their peer average, despite otherwise leading the series on life expectancy and mortality — the same gap that showed up as a Care Process failure resurfaces here as an outcome.

Outcomes are also the domain most vulnerable to being credited entirely to the health system. Japan’s own profile cautions against this directly, attributing its results partly to diet, social cohesion, and cultural factors outside the system’s control. That caution applies more broadly: an outcome score reflects lifestyle and social conditions as much as care delivery, which makes this domain harder to read as a pure verdict on system design than any of the other four.

The United States is the clearest exception to that caution — its gap is too large to attribute to anything but the system. Every major outcome measure sits far outside the range of the other nine countries: obesity at 42% against a 26% high-income average, maternal mortality nearly triple Canada’s, and firearm deaths with no comparable cause in any other country profiled. Where Japan’s or Sweden’s shortfalls are narrow and specific, the U.S. gap runs across nearly every measure at once.

The takeaway: outcomes tell you the least about system design of any domain in this series, precisely because they’re shaped by so much outside the system — except when the gap is large enough, and broad enough across every measure, to rule everything else out. The United States is the one case in this series where that bar is met.

Other Threads This Series Surfaced

Ten country profiles and five domains raise more questions than any one article can answer. A few threads recurred often enough, across different countries and different domains, to deserve their own dedicated treatment.

System Design and Financing

How a country arrives at universal coverage as a deliberate baseline objective — rather than treating it as an open policy question, the way the United States still does — shapes nearly everything downstream. Underneath that choice sit the financing mechanics this series has only sketched: how tax-based, contribution-based, and savings-based models actually work in practice; how risk pooling and regulated competition function in systems like the Netherlands and Germany; how risk-sharing arrangements — reinsurance, capitation, value-based contracts — differ from pooling itself; and how risk scores get calculated and applied across these systems. Policy and regulation deserve their own treatment too, since it’s the stewardship function, more than any financing label, that determines whether competition or pluralism serves patients or undermines them.

Delivery Model

Gatekeeper versus open-access primary care surfaced repeatedly across the domains above and merits a fuller comparison across all ten systems. Physician and nursing workforce planning — supply, geographic distribution, and specialty mix — is a related but distinct problem worth its own article. So is digital health integration: nearly every system in this series has invested heavily in it, and nearly every one still struggles with interoperability.

Demographic, Cultural, and Social Pressures

Aging societies and the financing of long-term care are two sides of the same problem and belong together. Mental health capacity is the one gap nearly every country in this series shares, regardless of architecture, spending, or overall performance — and it showed up as a weak point in nearly every domain covered here.

These threads are where this project goes next.

Additional Threads

A few additional threads that challenge healthcare systems include healthcare workforce planning, impacted of changing policies, pharmaceutical supply chains and drug pricing, and system resilience under shock (e.g., pandemics).

Closing Comments and What's Next

Running ten countries through the same five domains produced a consistent pattern rather than five separate stories. Financing architecture explained less than expected; design choices — benefit basket breadth, coordination mechanisms, risk pooling, workforce distribution — explained more. Every country had at least one specific weak spot, even the strongest overall performers, and the same gaps kept resurfacing regardless of architecture: mental health capacity, workforce distribution, coordination at the boundaries between systems. The United States was the recurring exception — not different in kind, but usually facing several of these gaps at once, without the coherent design that let other systems absorb any single failure.

That pattern is more useful than any individual country’s scorecard, and it’s why this project doesn’t end here. The threads above are where the next phase of this project goes: dedicated articles, grounded in OECD and other primary data, on the questions ten country profiles raised but couldn’t fully answer in one comparison.

Sources:

This country profile draws on comparative health system analyses from the Commonwealth Fund, the OECD, the WHO European Observatory, Statistics Sweden, the Swedish National Board of Health and Welfare, and peer-reviewed literature. Data reflect the most recent publications available as of 2024–2026.